Pulse Biosciences Q4 EPS $(0.26) Beats $(0.31) Estimate, Sales $264.000K Beat $250.000K Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 16.13 percent increase over losses of $(0.31) per share from
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 16.13 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $264.000 thousand which beat the analyst consensus estimate of $250.000 thousand by 5.60 percent.